Cancer Research UK-funded research

• Science & Technology

Work starts on a cancer vaccine for people with Lynch syndrome

LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types. LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types.

10 September 2024

• Science & Technology
• Charity News

£28m being invested to transform treatment for children with cancer

Cancer Research UK and LifeArc are investing £28m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers. Cancer Research UK and LifeArc are investing £28m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers.

5 September 2024

• Personal Stories

What's it like for your child to be part of a clinical trial?

Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like. Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like.

3 September 2024

• Science & Technology
• Health & Medicine

Childhood Cancer Awareness Month: How we've been tackling children’s and young people’s cancers

For Childhood Cancer Awareness Month, we're highlighting some our most important research into children's and young peoples' cancers over the past year. For Childhood Cancer Awareness Month, we're highlighting some our most important research into children's and young peoples' cancers over the past year.

1 September 2024

• Health & Medicine

Symptom triggered testing helps doctors diagnose ovarian cancer early

Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund. Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund.

15 August 2024

• Science & Technology

SU2C gives £7.5m more to improve treatments for children’s and young people’s cancers

Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients. Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients.

7 August 2024

• Health & Medicine

Bacon, sandwich ham and salami: How does processed and red meat cause cancer and how much matters?

How does bacon cause cancer? Research shows that moderate processed and red meat eating increases bowel cancer risk. How does bacon cause cancer? Research shows that moderate processed and red meat eating increases bowel cancer risk.

1 August 2024

• For Researchers

Exploring the promise of decentralised cancer clinical trials

Can decentralised trials become mainstream for cancer? The benefits can be manifold, but so can the challenges... Can decentralised trials become mainstream for cancer? The benefits can be manifold, but so can the challenges...

31 July 2024

• For Researchers

A winding road – the many adventures of a promising ADC

From obscure enzymes to the common cold… just how did spin out Myricx Bio put their ADC on the path to clinical development? From obscure enzymes to the common cold… just how did spin out Myricx Bio put their ADC on the path to clinical development?

9 July 2024

• Health & Medicine

NHS rolling out first targeted brain tumour treatment for children and young people

NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation. NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation.

13 June 2024